Connect with us

Life Sciences

Netherlands-Based Vivici Closes Seed Round to Bring Animal-Free Dairy Proteins to Market

Newcomer Vivici B.V., a Dutch B2B ingredients company, announces it has successfully closed its seed funding round to bring to market animal-free animal-free…

Published

9 months ago

on

This article was originally published by Vegeconomist

Newcomer Vivici B.V., a Dutch B2B ingredients company, announces it has successfully closed its seed funding round to bring to market animal-free animal-free dairy proteins made with precision fermentation, with strategic support from founding investors dsm-firmenich Venturing and Fonterra.

“…we will build Vivici into a precision fermentation leader that contributes to a future-proof food system.“

 
Headquartered at the Biotech Campus Delft and a dairy protein application lab in the Food Valley at NIZO food research, leveraging the Netherlands’ network and access to scale-up facilities and talent, the company draws on the founders’ experience in developing and scaling bioprocesses. Fonterra Chief Innovation & Brand Officer Komal Mistry-Mehta, says: “Vivici is an exciting opportunity to combine dsm-firmenich’s world-leading precision fermentation expertise with Fonterra’s world-leading dairy science and technology.”
 

 

Vivici fermentation process
© Vivici
Vivici was incorporated in December 2022 to bring animal-free dairy proteins to market, and in March 2023 the company hired Stephan van Sint Fiet as CEO, who joined from IFF where he led the Dairy Cultures & Food Enzymes business unit, building on the experience gained in the food enzymes business at Novozymes. Stephan previously helped scale two start-ups: Evolva, a company producing high-value natural products through fermentation, and Biognosys, an advanced proteomics company.
 

Pieter Wolters, MD of dsm-firmenich Venturing, comments: “We are thrilled to be a founding investor in Vivici BV’s Series Seed capital raise. Vivici has the foundation for success, and builds on multiple years of joint technology and application development, and is now well-positioned as an agile startup company.”

Stephan van Sint Fiet, CEO of Vivici, states: “I’m thrilled to work with such an experienced team, that knows what it takes to not only develop, but manufacture, register and commercialize great ingredients. Together, we will build Vivici into a precision fermentation leader that contributes to a future-proof food system.“

Learn more about Vivici at www.vivici.com 

proteomics

Continue Reading
Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Continue Reading

Trending